Introduction
Databases of genotoxicity and carcinogenicity can be used for gathering information about a specific chemical. In this case the data are used for a first-level risk analysis. The conclusions are less detailed and accurate than reading all the papers relevant to our analysis, but, it will be possible to reach an opinion in a much shorter time because the information contained in the databases is predigested. For this type of purpose, there are several requirements of the database: a) all useful data are easily accessible; b) the available database is as large and comprehensive as possible; and c) compilation and classification in the database is sufficiently detailed and accurate.
Databases of genotoxicity and carcinogenicity can be used not only for a risk analysis concerning an individual compound, but also for correlation studies between different types of short-term genotoxicity tests and long-term carcinogenicity tests for large sets of chemicals and for subsets of specific chemical classes. This type of extended use of databases also takes place in structure-activity relationship studies.
In this paper we consider the use of databases for quantitative correlation studies between carcinogenic potency and genotoxic potency in a given short-term test. Because of their log-normal distribution (1), we compare log of potencies. We have also made an attempt to compare qualitative and quantitative studies.
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Past Quantitative Correlation Studies
For a reconstruction of the story of quantitative correlation studies, which to our knowledge goes back to 1977 (2), we make reference to a recent review article published by our group (3) . In this review article we discussed the problems related to the computation ofgenotoxic and carcinogenic potencies. From the point of view of the use of databases of genotoxicity and carcinogenicity in quantitative correlation studies, we can disfinguish the papers published before 1985 and the papers published after 1985. Before 1985, for each published paper the authors had generated their own database both for a given type of genotoxicity and for carcinogenic potency.
Wehavepublished several quantitativecorrelation studies (4-8) before 1985, and for these studies we hadprepared our own databaseofcarcinogenicpotencies (9) . Inourdatabaseofcarcinogenic potencies, the treatment of the data coming from the original publications was substantially similar to the treatment ofdata in thedatabase ofGoldandco-workers (1J-12). The maindifference between the Golddatabaseandour database was thatourdatabase was an "ad hoc" database of 118 chemicals. These 118 chemicals were only the chemicals that we had used in correlation studies with short-term tests. After 1985, in quantitative correlation studies ofourgroup and other authors, the investigators started to use the database ofGold (10) (11) (12) for carcinogenic potencies.
In 1990 we started the using already existing databases also for genotoxicity data. More specifically, we have used the database ofWurgler and co-workers (13) for the qualitative component of the information in genotoxicity tests and the database ofWaters and co-workers (14) for the quantitative component ofthe information, always in genotoxicity tests. A summary of the results obtained in quantitative correlation studies by our group and other authors is shown in Tables 1, 2 , and 3. (19) ar, parametric correlation coefficient. As shown in Table 1 , for the test ofmutagenicity in Salmonella (+ microsomes), the average correlation level is about 0.4 (substantially unchanged for more than 10 years). The first value reported by Meselson and Russell (2) is artificially high because four chemicals with a poor correlation were arbitrarily discarded. In Table 2 , the correlation with carcinogenic potency ofdifferent types of short-term tests related to DNA damage and repair is shown. The average level of correlation is again around 0.4. The higher level reported by Lutz (18) is probably dependent on two reasons: a) only genotoxic compounds were considered and b) genotoxicity and carcinogenicity were examined always in the same species. In Table 3 , a more heterogeneous short-term tests are considered.
It is difficult to say ifthe correlation with carcinogenic potency of some of these short-term tests is significantly better than the correlation level found in the previous tests shown in Table 1 and  in Table 2 . The high correlation level obtained by Clive (20) for 25 chemicals is probably dependent on the concomitance of several factors: most ofthe compounds tested were potent genotoxic carcinogens; diethylstilbestrol and saccharin, which might well be nongenotoxic carcinogens, showed a good correlation between mutagenicity and carcinogenicity; and 4-acetyl-aminofluorene, benzo[e]pyrene, and diphenylnitrosamine were negative or questionable as carcinogens: a positive potency, well correlated with mutagenicity, was partially arbitrarily given.
New Quantitative Correlation Studies
The data reported in Table 4 were recently obtained from an intersection of the database of Waters (14) and the database of Gold (10) (11) (12) . Chromosomal aberrations and chromatid exchanges in vitro were investigated. We have not separated tests with and without metabolic activation to avoid the generation of sets of chemicals that are too small.
We have compared the two cytogenetic tests with the Salmonella test. The overall quantitative predictivity of the four in vitro cytogenetic tests seems significantly better than the predictivity of the Salmonella test.
This impression is confirmed by Table 5 , in which we have reported the performance of three different cytogenetic tests in vivo. The data have been obtained from the same intersection database (Waters + Gold) as in Table 4 .
From Table 1 (obtained from the data of several authors) we concluded an average predictivity for the Salmonella test around 0.4. In Tables 4 and 5 (and also for the sister chromatid exchange  data of Table 3 
Potency of Genotoxic and Nongenotoxic Carcinogens
Another example of using the databases of Gold (10) (11) (12) and Wurgler (13) is presented in Figure 2 . The database of Gold et al. was used for computing the log10 ofcarcinogenic potencies. The database of Wurgler was used as a source of qualitative responses for a large set of genotoxicity tests. Our intersection database was extended using 28 additional chemicals from the NTP (all the chemicals that could satisfy our conditions). In our study we defined as genotoxic those chemicals positive in at least three short-term tests and at least 75 % ofthe considered tests. We defined chemicals negative in at least three short-term tests and at least 75 % of the considered tests as nongenotoxic.
We found 141 chemicals positive for carcinogenicity in small rodents and at the same type genotoxic or nongenotoxic according to the definition given above. In general, genotoxic carcinogens were much more potent than nongenotoxic ones; however, the difference in potency varied significantly from chemical class to chemical class.
For nitrosocompounds, azocompounds, alcohols and phenols, miscellaneous compounds, and polycyclic aromatic hydrocarbons, we found that genotoxic carcinogens were about 20-100 times more potent than nongenotoxic ones. For aromatic and heterocyclic amines and amides, nitrocompounds, esters and carbamates, and hydrazine derivatives, we found that genotoxic carcinogens were 3-13 times more potent than nongenotoxic ones. Figure 2 . We conclude that genotoxicity seems to contribute significantly to carcinogenic potency. For some chemical classes this contribution is especially strong; it is weaker for others. A genotoxic carcinogen can have both genotoxic and epigenetic activities relevant for carcinogenicity, whereas a nongenotoxic carcinogen can have only epigenetic activities.
A qualitative observation in agreement with our quantitative analysis has been reported by Gold et al. (24) . These authors have observed that "more toxic carcinogens are significantly more likely to be mutagenic than less toxic carcinogen." In addition, going from a highest administered dose of less than 1 mg/kg/day to a highest administered dose of more than 1000 mg/kg/day, the fraction ofcarcinogens mutagenic in Salmonella decreases regularly from 71-76 %, to 28-13 % in mice and rats, respectively (L.S. Gold, personal communication).
Conclusions
In this short review we have given some examples of using databases for correlation studies and for the analysis of the carcinogenic potency of genotoxic and nongenotoxic carcinogens. In our opinion, two improvements in the existing databases would be most useful for the type of studies illustrated in this report: a) larger databases would make the conclusions that have been reached safer and more solid; b) better organization of the data would make it easier to extract subsets ofdata needed for a given type ofcorrelation study. Finally, we suggest that a network of investigators interested in improving the existing databases could be very useful, for accelerated progress in this important field.
For the future, we hope that frequencies of induced mutations and rearrangements in dominant and recessive proto-oncogenes in different target organs after treatment with chemical agents, will become available (a new type of database). The frequency of these irreversible alterations in the genome are the true end point to which short-term genotoxicity tests should be compared.
Tumor frequency is a complex function of stimulations of proliferation, clonal expansions of preneoplastic cells, modulations ofdifferentiation, and, finally, multiple irreversible alterations in the genome. Short-term tests of genotoxicity should be compared only with this last variable. New, entirely different tests are needed for assessing the other variables.
